Loading data
TCRXNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 10.33 m USD | 2.82 m USD | 21.05 m USD | 13.54 m USD | 10.14 m USD |
| Research and development expense | 114.15 m USD | 107.35 m USD | 88.15 m USD | 59.82 m USD | 44.95 m USD |
| Operating profit | -135.81 m USD | -134.82 m USD | -93.46 m USD | -66.64 m USD | -48.64 m USD |
| Interest expense | 2.77 m USD | 3.65 m USD | 3.76 m USD | 1.18 m USD | — |
| Income tax expense | 0 USD | — | — | — | — |
| Net income (reported basis) | -129.77 m USD | -127.5 m USD | -89.2 m USD | -66.22 m USD | -48.63 m USD |
| Basic earnings per share | -1 USD/share | -1.14 USD/share | -1.36 USD/share | -2.75 USD/share | -4.17 USD/share |
| Diluted earnings per share | -1 USD/share | -1.14 USD/share | -1.36 USD/share | -2.75 USD/share | -4.17 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.